Rafferty Asset Management
ORTX

Rafferty Asset Management’s Orchard Therapeutics plc American Depositary Shares ORTX Stock Holding History

Rafferty Asset Management’s Portfolio ORTX Stock Details ORTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-65,201
Closed -$1.5M – 1341
2021
Q3 		$1.5M Sell
65,201
-6,881
-10% -$205K 0.01% 710
2021
Q2 		$3.16M Buy
72,082
+5,378
+8% +$300K 0.02% 490
2021
Q1 		$4.84M Buy
66,704
+57,073
+593% +$4.05M 0.03% 286
2020
Q4 		$416K Buy
+9,631
New +$431K ﹤0.01% 726

Other funds holding ORTX

Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
CA
CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

Rafferty Asset Management's ORTX Position: Q4 2021 in Review

Rafferty Asset Management sold out of Orchard Therapeutics plc American Depositary Shares (ORTX) in Q4 2021, closing a stake of 65,201 shares — an estimated $1.5M sold.

Rafferty Asset Management first reported a position in ORTX in Q4 2020 and held it in 4 quarters. The position peaked at $4.84M in Q1 2021. 72 funds tracked by Wall St. Rank hold ORTX as of Q4 2021.

  • Rafferty Asset Management reported no remaining Orchard Therapeutics plc American Depositary Shares position as of Q4 2021 after selling out during the quarter.
  • Rafferty Asset Management sold 65,201 Orchard Therapeutics plc American Depositary Shares shares in Q4 2021, an estimated $1.5M.
  • Rafferty Asset Management first reported a position in Orchard Therapeutics plc American Depositary Shares in Q4 2020 and held it in 4 quarters.
  • Rafferty Asset Management's Orchard Therapeutics plc American Depositary Shares position peaked at $4.84M in Q1 2021.
  • 72 funds tracked by Wall St. Rank held Orchard Therapeutics plc American Depositary Shares as of Q4 2021.

Based on Rafferty Asset Management's 13F filing for Q4 2021, filed 10 Feb 2022.